Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma

다국어 초록 (Multilingual Abstract)

Background: Calcium phosphate (CaP) based nanoparticles are considered to be ideal drug carriers for delivery of anticancer drugs because of their excellent biocompatibility and pH responsiveness. However, CaP nanoparticles have the problems of limited drug load capacity, initial burst release, and short-term release. Thus, we prepared the CaP nanocomposites containing anticancer drug such as caffeic acid (CA-NP), chlorogenic acid (CG-NP), or cisplatin (CP-NP) in the presence of alginate as a polymer template to control the release rate of drugs. Results: The drug-loaded CaP nanocomposites exhibited spherical shape with a size of under 100 nm and the size of nanocomposites was hardly affected by the addition of drug. UV-visible spectroscopic analysis confirmed the insertion of drug into the CaP nanocomposites. These nanocomposites showed an initial burst release of drug, followed by a prolonged release, in which the release profile of drugs was depended on the solution pH. In addition, the drug-loaded CaP nanocomposites revealed anticancer activity on human osteosarcoma in a manner dependent on concentration of drugs and time. Conclusions: The drug-loaded CaP nanocomposites can contribute to the development of a new generation of controlled drug release carriers for chemotherapy of cancers.

참고문헌 (Reference)

1 Wang S, "Towards sustained delivery of small molecular drugs using hydroxyapatite microspheres as the vehicle" 21 : 268-272, 2010

2 Erdogan S, "The natural flavonoid apigenin sensitizes human CD44+ prostate cancer stem cells to cisplatin therapy" 88 : 210-217, 2017

3 Fang J, "The EPR effect : unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect" 63 : 136-151, 2011

4 Naso LG, "Promising antioxidant and anticancer (human breast cancer) oxidovanadium (IV) complex of chlorogenic acid. Synthesis, characterization and spectroscopic examination on the transport mechanism with bovine serum albumin" 135 : 86-99, 2014

5 Salama A, "Preparation of polyelectrolyte/calcium phosphate hybrids for drug delivery application" 113 : 500-506, 2014

6 Vergaro V, "Nanostructured polysaccharidic microcapsule for intracellular release of cisplatin" 99 : 187-195, 2017

7 Fujie T, "Evaluation of substrata effect on cell adhesion properties using freestanding poly(l-lactic acid) nanosheets" 27 : 13173-13182, 2011

8 Ding Y, "Encapsulation of cisplatin in a pegylated calcium phosphate nanoparticle(CPNP)for enhanced cytotoxicity to cancerous cells" 493 : 181-189, 2017

9 Lee GS, "Direct deposited porous scaffolds of calcium phosphate cement with alginate for drug delivery and bone tissue engineering" 7 : 3178-3186, 2011

10 Rajkumar M, "Development of nanocomposites based on hydroxyapatite/sodium alginate: synthesis and characterization" 62 : 469-479, 2011

11 Zhou ZF, "Calcium phosphate-phosphorylated adenosine hybrid microspheres for anti-osteosarcoma drug delivery and osteogenic differentiation" 121 : 1-14, 2017

12 Dorozhkin SV, "Amorphous calcium (ortho)phosphates" 6 : 4457-4475, 2010

13 Cao T, "A novel drug delivery carrier based on α-eleostearic acid grafted hydroxyapatite composite" 11 : 125-133, 2014

14 Guo D, "A caffeic acid mediated facile synthesis of silver nanoparticles with powerful anti-cancer activity" 134 : 229-234, 2015